AngioSoma, Inc. (SOAN) financial statements (2021 and earlier)

Company profile

Business Address 2500 WILCREST DRIVE, 3RD FLOOR
HOUSTON, TX 77042
State of Incorp. NV
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6681100921466
Cash and cash equivalents6681100921466
Receivables      5
Inventory, net of allowances, customer advances and progress billings22404   
Inventory22404   
Prepaid expense 51 111
Other undisclosed current assets   16   
Total current assets:698914111215711
Noncurrent Assets
Property, plant and equipment1111   
Oil and gas property, full cost method      255
Long-term investments and receivables    101156
Long-term investments    101156
Other undisclosed noncurrent assets   12   
Total noncurrent assets:111131011311
TOTAL ASSETS:70901421252517322
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:144133135137137165131
Interest and dividends payable2272272282321476335
Other undisclosed accounts payable and accrued liabilities(83)(94)(93)(95)(10)10296
Debt2152151731002015066
Asset retirement obligation      15
Due to related parties1132333516014128 
Other undisclosed current liabilities28716816869920738935
Total current liabilities:759749828995505732247
Noncurrent Liabilities
Long-term debt and lease obligation    696944
Long-term debt, excluding current maturities    696944
Liabilities, other than long-term debt    753419
Accounts payable and accrued liabilities    753413
Asset retirement obligations      6
Other undisclosed noncurrent liabilities     26 
Total noncurrent liabilities:    14412863
Total liabilities:759749828995649860310
Stockholders' equity
Stockholders' equity attributable to parent, including:(689)(659)(685)(871)(624)(843)13
Preferred stock      1
Common stock4554361706946349
Additional paid in capital6,1936,1181,2252,0651,521(366)4,424
Accumulated other comprehensive income (loss)   1(1) 21
Accumulated deficit(7,340)(7,215)(6,674)(5,999)(5,182)(3,502)(4,442)
Other undisclosed stockholders' equity attributable to parent224,5922,9922,9932,992 
Total stockholders' equity:(689)(659)(685)(871)(624)(843)13
TOTAL LIABILITIES AND EQUITY:70901421252517322

Income statement (P&L) ($ in thousands)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Revenues 00110 42
Revenue, net  42
Realized investment gains    10  
Cost of revenue
(Cost of Goods and Services Sold)
(38)(38)(0)(0)  (18)
Gross profit:(38)(38)0110 25
Operating expenses(252)(266)(316)(352)(461) (740)
Other undisclosed operating income (loss)    (10) 18
Operating loss:(290)(304)(316)(351)(461) (698)
Nonoperating income90  611 453
Investment income, nonoperating    11  
Debt instrument, convertible, beneficial conversion feature      453
Other nonoperating income (expense)(103)  6   
Interest and debt expense(215)(238)(349)(464)(1,229) (388)
Other undisclosed income from continuing operations before equity method investments, income taxes      502
Net loss:(415)(542)(664)(809)(1,680) (131)
Other undisclosed net loss attributable to parent(90) (11)(7)  (954)
Net loss attributable to parent:(505)(542)(675)(817)(1,680) (1,086)
Preferred stock dividends and other adjustments  (1,600)    
Net loss available to common stockholders, diluted:(505)(542)(2,275)(817)(1,680) (1,086)

Comprehensive Income ($ in thousands)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net loss:(415)(542)(664)(809)(1,680) (131)
Other comprehensive loss    (1)  
Comprehensive loss:(415)(542)(664)(809)(1,681) (131)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (12)(5)  (950)
Comprehensive loss, net of tax, attributable to parent:(415)(542)(676)(815)(1,681) (1,082)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: